2014

1. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: Results of the PROTECTION AMI randomized controlled trial

   European Heart Journal, Vol. 35, Núm. 37, pp. 2516-2523